References
- Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet 2005;366:397-408. https://doi.org/10.1016/S0140-6736(05)67025-0
- Suzuki K. Diagnosis of malignant pleural mesothelioma: thoracoscopic biopsy and tumor marker. Nihon Geka Gakkai Zasshi 2009;110:333-7.
- Dieter RA Jr, Kuzycz GB. Complications and contraindications of thoracoscopy. Int Surg 1997;82:232-9.
- Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 1997;111:106-9. https://doi.org/10.1378/chest.111.1.106
- Campbell NP, Kindler HL. Update on malignant pleural mesothelioma. Semin Respir Crit Care Med 2011;32: 102-10. https://doi.org/10.1055/s-0031-1272874
- McLaughlin KM, Kerr KM, Currie GP. Closed pleural biopsy to diagnose mesothelioma: dead or alive? Lung Cancer 2009;65:388-9. https://doi.org/10.1016/j.lungcan.2009.05.005
- Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 1993;72:389-93. https://doi.org/10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V
- Agarwal PP, Seely JM, Matzinger FR, MacRae RM, Peterson RA, Maziak DE, et al. Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy. Radiology 2006;241:589-94. https://doi.org/10.1148/radiol.2412051020
- Kawai T, Greenberg SD, Truong LD, Mattioli CA, Klima M, Titus JL. Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung. Am J Pathol 1988;130:401-10.
- Ordonez NG. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. Mod Pathol 1998;11:929-33.
- Chhieng DC, Yee H, Schaefer D, Cangiarella JF, Jagirdar J, Chiriboga LA, et al. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions. Cancer 2000;90: 194-200. https://doi.org/10.1002/1097-0142(20000625)90:3<194::AID-CNCR8>3.0.CO;2-K
- Ordonez NG. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 1998;22: 1215-21. https://doi.org/10.1097/00000478-199810000-00006
- Hamamoto J, Notsute D, Tokunaga K, Sasaki J, Kojima K, Saeki S, et al. Diagnostic usefulness of endobronchial ultrasound-guided transbronchial needle aspiration in a case with malignant pleural mesothelioma. Intern Med 2010;49:423-6. https://doi.org/10.2169/internalmedicine.49.2825
- Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez CA, Lee JH, et al. Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg 2009;88:862-8. https://doi.org/10.1016/j.athoracsur.2009.05.022
Cited by
- Malignant Mesothelioma Diagnosed by Bronchoscopic Biopsy vol.78, pp.3, 2015, https://doi.org/10.4046/trd.2015.78.3.297
- Sampling pleural nodules with an EBUS scope: A novel application vol.25, pp.None, 2013, https://doi.org/10.1016/j.rmcr.2018.06.004